Ingredients

EU R&D keeps active

EU R&D keeps active

There has been 'unprecedented development' in terms of the
Community's research policy in the last year claims the European
Commission's 2002 annual report on technological research and
development (RTD) in 2001.

Biotech appeals to the angels

Biotech appeals to the angels

Venture capital investments in biotechnology and medical device
companies combined to total $4.7 billion (€4.4bn) in 2002, or 22
per cent of all investing, representing the highest proportion in
seven years, according to the MoneyTree...

The yolk of the matter

The yolk of the matter

The prospect of using chicken eggs as commercial 'biofactories' for
the production of protein-based drugs has moved a step closer with
the announcement of a study showing that transgenic cockerels can
pass on an introduced...

Plants ooze vitamin C

Plants ooze vitamin C

Scientists in the US report this week that they have developed a
new technology that increases the amount of vitamin C in plants,
including grains, by increasing the amount of the enzyme that is
responsible for recycling vitamin C.

Sigma Tau with Thuris

Sigma Tau with Thuris

Drug development and biomedical company Thuris and Italian
pharmaceutical company Sigma-Tau Industrie Farmaceutiche Riunite on
Monday announced an expansion of their ongoing research
collaboration to develop compounds to combat brain...